Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 65 Next >>

Filter Applied: old age,neurology of (Click to remove)

Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024

Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
Ann Neurol 91:78-88, Polymeris, A.A.,et al, 2022

Incidence, Risk Factors, and Outcomes of Stroke Following Cardiac Transplantation
Stroke 52:e720-e724, Alnsasra, H.,et al, 2021

Improved Stroke Prevention in Atrial Fibrillation after the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 49:2122-2128, Forslund, T.,et al, 2018

Ischemic Optic Neuropathies
NEJM 372:2428-2436, Biousse, V. & Newman, N.J., 2015

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015

Intracranial Atherosclerosis
Lancet 383:984-998, Qureshi, A. & Caplan, L.R., 2014

Risk of Stroke After Coronary Artery Bypass Grafting Effect of Age and Comorbidities
Stroke 43:38-43, Merie, C.,et al, 2012

New Antithrombotic Drugs for Atrial Fibrillation: Caution is Needed
Lancet 379:e24, Bell,S.,et al, 2012

Anticoagulant Loses its Lustre
Lancet 379:301, Mullar,A., 2012

Serious Cardiac Arrhythmias after Stroke Incidence, Time Course, and Predictors - A Systematic, Prospective Analysis
Stroke 43:2892-2897, Kallmunzer, B.,et al, 2012

Spontaneous Primary Intraventricular Hemorrhage: Clinical Features and Early Outcome
ISRN Neurology ED498303, Arboix, A.,et al, 2012

Cerebral Microbleeds Are Predictive of Mortality in the Elderly
Stroke 42:638-644, Altmann-Schneider,I.,et al, 2011

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011

Clinicopathologic Conference, Thymoma with Paraneoplastic Myasthenia Gravis, Polymyositis and Myocarditis, and Brain Stem Encephalitis
NEJM 365:2413-2422, Case 39-2011, 2011

New Aspects on Patients Affected by Dysferlin Deficient Muscular Dystrophy
JNNP 81:946-953, Klinge,L.,et al, 2010

Independent Predictors of Stroke in Patients with Atrial Fibrillation
Neurol 69:546-554, The Stroke Risk in Atrial Fibrillation Working Group, 2007

Warfarin Versus Aspirin for Stroke Prevention in an Elderly Community Population With Atrial Fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A Randomised Controlled Trial
Lancet 370:493-503,460, Mant,J.,et al, 2007

Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial
Stroke 38:2965-2971, Ford,G.A.,et al, 2007

Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
NEJM 357:2262-2268, Handke,M.,et al, 2007

Long-Term Survival After Carotid Endarterectomy for Asymptomatic Stenosis
Stroke 37:2886-2891, Kragsterman,B.,et al, 2006

Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004

Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004

Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004

Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004

Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001

Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000

Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000

Intracranial Hemorrhage Associated With Thrombolytic Therapy for Eldery Patients With Acute Myocardial Infarction
Stroke 31:1802-1811, Brass,L.M. et al, 2000

Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the Elderly
Arch Int Med 159:38-44, Bots,M.L.,et al, 1999

Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
NEJM 340:14-22, O'Leary,D.H.,et al, 1999

Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999

Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999

Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999

Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999

Cerebral Amyloid Angiopathy:Propsects for Clinical Diagnosis and Treatment
Neurol 52:690-694, Greenberg,S.M., 1998

Warfarin Use Following Ischemic Stroke Among Medicare Patients with Atrial Fibrillation
Arch Int Med 158:2093-2100, Brass,L.A.,et al, 1998

Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997

Embolic Brain Infarction in Nonrheumatic Atrial Fibrillation
Neurol 48:1593-1597, Yamanouchi,H.,et al, 1997

Mitral Valve Strands and the Risk of Ischemic Stroke in Elderly Patients
Stroke 28:1574-1578, Cohen,A.,et al, 1997

Paroxysmal Atrial Fibrillation:High Frequency of Embolic Brain Infarction in Elderly Autopsy Patient
Neurol 49:1691-1694, Yamanouchi,H.,et al, 1997

Bleeding During Antithrombotic Therapy in Patients with Atrial Fibrillation
Stroke Prevention in Atrial Fib Invest, Arch Int Med 156:409-4161996., , 1996

Adverse Cerebral Outcomes After Coronary Bypass Surgery
NEJM 335:1857-1863, Roach,G.W.,et al, 1996

Physician Attitudes About Anticoagulation for Nonvalvular Atrial Fibrillation in the Elderly
Arch Int Med 155:277-281, McCrory,D.C.,et al, 1995

Predicting the Occurrence of Adverse Events after Coronary Artery Bypass Surgery
Ann Int Med 118:18-24, Geraci,J.M.,et al, 1993

Predicting Complications of Carotid Endarterectomy
Stroke 24:1285-1291, McCrory,D.C.,et al, 1993

Transient Ischemic Attacks in Younger and Older Patients:A Comparative Study of 798 Patients in South Africa
Stroke 24:947-953, Giovannoni,G.&Fritz,V.U., 1993



Showing articles 0 to 50 of 65 Next >>